Oded Levy has over 25 years of investment experience.
Mr. Levy is the Managing Partner of Blue Ox Healthcare Partners LLC, a family office investing in the health care and technology sectors. A complete list of current and previous investments is available at the company’s web site at www.blueoxcapital.com. (More information re the specific investments and track record is available)
From 1999 to January 2005, Mr. Levy was a Principal with Oracle Partners, L.P. a private investment firm specializing in public securities investing and merchant banking in the healthcare, bioscience and related industries. The firm managed approximately $1 billion of capital in investment partnerships funded by institutional investors, healthcare executives and private investors.
Prior to April 1999, Mr. Levy was a partner with Will K. Weinstein, managing Jackson Square Partners, LP, a $100 million hedge fund headquartered in San Francisco. Mr. Levy focused on investing in special situations.
From 1994 to 1998, Mr. Levy was a Partner, member of the Executive Committee, and the head trader at Genesis Merchant Group Securities (“GMGS”); a San Francisco based investment bank. With over $30 million in revenues, GMGS was consistently ranked in the top 50 institutional brokers. At GMGS, Mr. Levy had complete authority regarding capital commitment and full responsibility for the firm’s trading profit & loss. Mr. Levy was also responsible for trading and hedging the firm’s net exposure, managing GMGS’ position & block trading, facilitating customer’s orders and developing new business. In June 1998, GMGS merged with JW Charles, a Florida retail brokerage firm, which was later merged into Fleet Bank. Among the firm partners were, Will K. Weinstein, Philip Stapelton, Sam Zell and The Pritzker family.
Between 1989 and 1993, Mr. Levy was Senior Vice President, Investments of Bering Holdings, Inc., (“Bering”) the investment arm of publicly traded MAXXAM, Inc. (“MXM” American Stock Exchange), a Fortune 200 company with over $2.5 billion in revenues. While at Bering, Mr. Levy co-managed a $150 million hedge fund specializing in risk arbitrage and distressed securities, which produced superior returns.
Prior to joining Bering, Mr. Levy was a Vice President at Remington Partners, L.P., an investment company specializing in leveraged acquisitions. Among Remington founders were Charles E. Hurwitz (CEO & Chairman of MAXXAM), J. Livingston Kosberg, and Clarence Mayer. Mr. Levy’s responsibilities included identifying potential acquisition candidates, analyzing corporate and financial data, analyzing industry trends, conducting due diligence and formalizing leveraged buyout proposals.
From 1987 to 1988, Mr. Levy was associated with First Texas Merchant Group, the M&A and LBO arm of First Texas/Gibraltar Savings with $9 billion in assets, where he was actively involved in closing 18 transactions to which the bank committed in excess of $250 million. Mr. Levy began his career as a corporate finance analyst at Bear Stearns in NYC.
Sheila H. Schweitzer
Ms. Schweitzer currently holds the positions of investor, board member and CEO PatientMatters, LLC. Century Capital and Ms. Schweitzer formed PatientMatters in 2012. PatientMatters is a purpose built Healthcare Receivable company designed to enhance the patient’s experience while improving patient receivable performance for healthcare providers. PatientMatters has acquired Kramer Technologies and Medical Advocacy Services for Healthcare (MASH) as the technology and services platform for the go forward company.
Ms. Schweitzer has focused professionally on the revenue cycle management industry for the past 30 years. In such capacity, Ms. Schweitzer has held numerous founder and executive/industry association leadership roles with several companies and organizations. Ms. Schweitzer joined Caremedic in March of 2003 as COO and was appointed Chairman of the Board and CEO in September 2003. Under her leadership Caremedic achieved a lead position in the HCIT revenue cycle market. During her tenure revenue and EBITDA grew by 650 percent and Caremedic successfully brought to market the first enterprise class revenue management system, the Electronic Financial Record (eFR). Ms. Schweitzer sold Caremedic to Ingenix in December 2009.
Prior to joining CareMedic, Ms. Schweitzer was recruited to MedUnite Inc, a consortium of seven health plans -- Aetna, Cigna, Wellpoint, Anthem, Oxford, Healthnet, and PacificCare – which was formed to develop a network that connects physicians with payers for the electronic exchange of health data such as eligibility, claim status, referrals, authorizations and claim submission. Ms. Schweitzer served in a consulting capacity to MedUnite in an initiative to position the Company for a sale. During her consulting tenure, Ms. Schweitzer served as Executive Vice President and Chief Operating Officer of MedUnite as well as a member of the firm’s Executive Committee. Following her successful effort to rationalize overhead and functionalize MedUnite’s web product offering for real-time transaction processing, Ms Schweitzer managed a multi-bid auction process, which led to the Company’s sale to ProxyMed, Inc. in December 2002.
Prior to MedUnite, Ms. Schweitzer served as Chief Executive Officer of Presideo, Inc., which developed and marketed a biometric security technology for HCIT systems. Presideo was funded by Mayo Medical Ventures and Safeguard Scientifics, among others. Ms. Schweitzer led the Company from its inception to product launch (following an 18-month product development period) and recruited a host of luminary hospital clients, including MD Anderson, Mayo Clinic - Jacksonville and Mayo Clinic - Scottsdale. Presideo was later sold to Smart Biometrics, Inc
Prior to Presideo, Ms. Schweitzer served as Senior Vice President of Operations with ENVOY Corporation (now a division of Emdeon), the nation’s largest healthcare transactions service company. In this capacity, Ms. Schweitzer oversaw the management of 1,600 employees and acted in a direct reporting relationship to the Co-CEO’s of ENVOY while serving on the firm’s Executive Committee. During her six-year tenure, Ms. Schweitzer led the healthcare transaction processing operations of ENVOY from inception to over $280 million in revenues, representing over 30 million transactions processed per month. Further, Ms. Schweitzer managed the due diligence, negotiation and operational integration of 18 acquisitions and oversaw the sale of ENVOY’s credit card processing division to First Data Corporation.
In addition to her executive positions, Ms. Schweitzer has served on the Advisory Board of NDCHealth and as a consultant to Wellpoint Health Networks, Inc. , Aetna Insurance, the National Blue Cross Blue Shield Association, and Mysis Inc, among others. Further, Ms. Schweitzer has testified before the US Congress on the standardization of electronic healthcare claims transactions and before the Ministers of Health of the European Union on the topic of electronic transaction processing.
Ms. Schweitzer is a member of various industry organizations including HIMSS Medical Banking Project – the financial sector of HIMSS representing vendors of HCIT systems, the American National Standards Institute (ANSI X12.N) – the governing body for HIPAA legislation, the Workgroup for Electronic Data Interchange (WEDI) – an EDI-focused organization of private sector healthcare providers and payers created per the direction of the Secretary of the Dept of Health and Human Services, and the National Council for Paid Drug Programs (NCPDP). Ms. Schweitzer served as a Founding Member of WEDI, AFEHCT, and the Electronic Healthcare National Accreditation Committee (EHNAC). Her industry association leadership positions included Chairman of AFEHCT (for 2005), member of the WEDI Foundation Board (2001 and 2002). Ms. Schweitzer was awarded Person of the Year by HIMSS Medical Banking Project in 2008 and was also nominated as Entrepreneur of the Year in Louisville, Kentucky in 1993 and was a founder and author of a whitepaper for EDI-USA.
Ms. Schweitzer currently holds board seats at National Electronic Attachment Inc., the leader in claim attachment technology, Phasient a web based training company, and Benchmark Revenue Management, a company focused on revenue cycle improvements for hospitals and large physician organizations. Ms. Schweitzer recently conducted the sale of Benchmark to Avedyne in December of 2011. Ms. Schweitzer held a board position with Recondo Inc. a leading healthcare technology company. Ms. Schweitzer holds a B.S degree in Chemistry from Western Kentucky University.
Glen Surnamer brings 20 years of vast experience across capital markets, asset management, operations/risk management, and entrepreneurship to Blue Ox.
Mr. Surnamer’s career commenced in 1994 with Surnamer Weissman and Co., a New York Stock Exchange member firm that served as Specalists in a variety of NYSE listed companies. After being acquired in 1999 by publicly traded global broker-dealer Van der Moolen NV, he became a partner of the newly formed subsidiary VDM USA. From 1999-2005 Glen was a senior specialist and risk manager, running his own team of traders and serving as an NYSE Floor Official for two years. From 2006 to 2007 he served as Chief Operating Officer of VDM USA where he led a restructuring of the company as well as a successful development of its internal control program and compliance with Sarbanes-Oxley.
Glen spent 2008 as COO of Curex Capital, a startup investment manager focused on development of algorithmic trading strategies and structured products for the FX markets.
After the economic crisis Glen acquired a newly found sense of purpose to support small businesses and entrepreneurship. Since 2009 he has successfully invested in and advised to a variety of private companies in the financial, legal services, and strategy/branding industries. As a global thinker with deep knowledge across the investment spectrum, Glen has been a valued advisor and board member to several successful small businesses. One of his core projects was to lead finance, operations, and business development for Bookigee Inc., a disruptive technology startup providing new data driven solutions to the publishing industry.
With a BA in English from Emory University and an MBA in Finance from NYU Stern, Glen has a unique anlaytical style and approach to business that combines liberal arts thinking, with financial knowledge, and an entrepreneurial spirit.